Lithium Therapy
Lithium Therapy
活動訊息
中文書、漫畫輕小說5折起、電子書35元起，全館滿$1,000送100點金幣
內容簡介
Lithium is a first choice mood-stabilizer for the maintenance treatment of bipolar disorder. The drug can augment antidepressants in treatment-resistant depression and exerts anti-suicidal, immunomodulatory, and neuroprotective action. For the author of this book, clinical use and mechanism of therapeutic action of lithium have been a leitmotiv since 1970. It resulted in multiple publications, and the book "Lithium - the amazing drug in psychiatry", published in 2020. Thirty-nine papers from the recent decade were selected here, in all of them Prof. Rybakowski is the first or the last author.
The editorial in Neuropsychobiology on the 60th anniversary of lithium entering modern psychiatry is followed by the 2010 update on lithium in neuropsychiatry. The studies of an association between lithium efficacy and temperament as well as candidate genes are presented. The effects of lithium on cognitive, kidney, and thyroid functions were covered in many articles. The studies on lithium's biochemical mechanism with very small embryonic-like stem cells and mRNA of neuronal and glial markers are shown.
Ultra-long-term therapy with lithium is described in five patients receiving lithium for more than 40 years, and in another paper, presenting a patient on lithium for half a century. Given the clinical and biological properties of lithium, this drug is presently greatly underutilized and efforts should be undertaken for challenging lithium's skepticism and optimizing its long-term administration. Such a message was expressed in a special paper published in 2018 and in several "state of the art" papers on lithium in 2020. About the Author:
Prof. Janusz K. Rybakowski was the Head, Department of Adult Psychiatry, Poznan University of Medical Sciences, 1995-2016, the Chairman, Department of Psychiatry, Medical Academy, Bydgoszcz, 1985-1995, the NIH Fogarty Research Fellow, University of Pennsylvania, Philadelphia, 1976-1977. He was the President of the Polish Psychiatric Association, 1998-2001. Authored over 700 scientific articles, Hirsch Index 56, and the books "The Faces of Manic-Depressive Illness" (2009) and "Lithium - the Amazing Drug in Psychiatry" (2020). A member of the Editorial Board of 16 international journals. In 2012, received the Lifetime Achievement Award of the European Bipolar Forum, in 2015, the Lifetime Achievement Award in Biological Psychiatry of the World Federation of the Societies of Biological Psychiatry, and 2018, the Mogens Schou scientific award of the International Society of Bipolar Disorders.
The editorial in Neuropsychobiology on the 60th anniversary of lithium entering modern psychiatry is followed by the 2010 update on lithium in neuropsychiatry. The studies of an association between lithium efficacy and temperament as well as candidate genes are presented. The effects of lithium on cognitive, kidney, and thyroid functions were covered in many articles. The studies on lithium's biochemical mechanism with very small embryonic-like stem cells and mRNA of neuronal and glial markers are shown.
Ultra-long-term therapy with lithium is described in five patients receiving lithium for more than 40 years, and in another paper, presenting a patient on lithium for half a century. Given the clinical and biological properties of lithium, this drug is presently greatly underutilized and efforts should be undertaken for challenging lithium's skepticism and optimizing its long-term administration. Such a message was expressed in a special paper published in 2018 and in several "state of the art" papers on lithium in 2020. About the Author:
Prof. Janusz K. Rybakowski was the Head, Department of Adult Psychiatry, Poznan University of Medical Sciences, 1995-2016, the Chairman, Department of Psychiatry, Medical Academy, Bydgoszcz, 1985-1995, the NIH Fogarty Research Fellow, University of Pennsylvania, Philadelphia, 1976-1977. He was the President of the Polish Psychiatric Association, 1998-2001. Authored over 700 scientific articles, Hirsch Index 56, and the books "The Faces of Manic-Depressive Illness" (2009) and "Lithium - the Amazing Drug in Psychiatry" (2020). A member of the Editorial Board of 16 international journals. In 2012, received the Lifetime Achievement Award of the European Bipolar Forum, in 2015, the Lifetime Achievement Award in Biological Psychiatry of the World Federation of the Societies of Biological Psychiatry, and 2018, the Mogens Schou scientific award of the International Society of Bipolar Disorders.
配送方式
-
台灣
- 國內宅配：本島、離島
-
到店取貨：
-
海外
- 國際快遞：全球
訂購/退換貨須知
加入金石堂 LINE 官方帳號『完成綁定』，隨時掌握出貨動態：
商品運送說明：
- 本公司所提供的產品配送區域範圍目前僅限台灣本島。注意！收件地址請勿為郵政信箱。
- 商品將由廠商透過貨運或是郵局寄送。消費者訂購之商品若無法送達，經電話或 E-mail無法聯繫逾三天者，本公司將取消該筆訂單，並且全額退款。
- 當廠商出貨後，您會收到E-mail出貨通知，您也可透過【訂單查詢】確認出貨情況。
- 產品顏色可能會因網頁呈現與拍攝關係產生色差，圖片僅供參考，商品依實際供貨樣式為準。
- 如果是大型商品（如：傢俱、床墊、家電、運動器材等）及需安裝商品，請依商品頁面說明為主。訂單完成收款確認後，出貨廠商將會和您聯繫確認相關配送等細節。
- 偏遠地區、樓層費及其它加價費用，皆由廠商於約定配送時一併告知，廠商將保留出貨與否的權利。
提醒您！！
金石堂及銀行均不會請您操作ATM! 如接獲電話要求您前往ATM提款機，請不要聽從指示，以免受騙上當！
退換貨須知：
**提醒您，鑑賞期不等於試用期，退回商品須為全新狀態**
-
依據「消費者保護法」第19條及行政院消費者保護處公告之「通訊交易解除權合理例外情事適用準則」，以下商品購買後，除商品本身有瑕疵外，將不提供7天的猶豫期：
- 易於腐敗、保存期限較短或解約時即將逾期。（如：生鮮食品）
- 依消費者要求所為之客製化給付。（客製化商品）
- 報紙、期刊或雜誌。（含MOOK、外文雜誌）
- 經消費者拆封之影音商品或電腦軟體。
- 非以有形媒介提供之數位內容或一經提供即為完成之線上服務，經消費者事先同意始提供。（如：電子書、電子雜誌、下載版軟體、虛擬商品…等）
- 已拆封之個人衛生用品。（如：內衣褲、刮鬍刀、除毛刀…等）
- 若非上列種類商品，均享有到貨7天的猶豫期（含例假日）。
- 辦理退換貨時，商品（組合商品恕無法接受單獨退貨）必須是您收到商品時的原始狀態（包含商品本體、配件、贈品、保證書、所有附隨資料文件及原廠內外包裝…等），請勿直接使用原廠包裝寄送，或於原廠包裝上黏貼紙張或書寫文字。
- 退回商品若無法回復原狀，將請您負擔回復原狀所需費用，嚴重時將影響您的退貨權益。
商品評價